131 related articles for article (PubMed ID: 17214579)
1. Viral anti-inflammatory reagents: the potential for treatment of arthritic and vasculitic disorders.
Munuswamy-Ramanujam G; Khan KA; Lucas AR
Endocr Metab Immune Disord Drug Targets; 2006 Dec; 6(4):331-43. PubMed ID: 17214579
[TBL] [Abstract][Full Text] [Related]
2. The serpin saga; development of a new class of virus derived anti-inflammatory protein immunotherapeutics.
Lucas A; Liu L; Dai E; Bot I; Viswanathan K; Munuswamy-Ramunujam G; Davids JA; Bartee MY; Richardson J; Christov A; Wang H; Macaulay C; Poznansky M; Zhong R; Miller L; Biessen E; Richardson M; Sullivan C; Moyer R; Hatton M; Lomas DA; McFadden G
Adv Exp Med Biol; 2009; 666():132-56. PubMed ID: 20054981
[TBL] [Abstract][Full Text] [Related]
3. Serpins, the vasculature, and viral therapeutics.
Richardson J; Viswanathan K; Lucas A
Front Biosci; 2006 Jan; 11():1042-56. PubMed ID: 16146796
[TBL] [Abstract][Full Text] [Related]
4. Viral serine protease inhibitors as anti-atherosclerotic therapy.
Bot I; van Berkel TJ; Biessen EA
Curr Opin Investig Drugs; 2007 Sep; 8(9):729-35. PubMed ID: 17729184
[TBL] [Abstract][Full Text] [Related]
5. Amelioration of antigen induced arthritis in rabbits treated with a secreted viral serine proteinase inhibitor.
Maksymowych WP; Nation N; Nash P; Macen J; Lucas A; McFadden G; Russell AS
J Rheumatol; 1996 May; 23(5):878-82. PubMed ID: 8724302
[TBL] [Abstract][Full Text] [Related]
6. The serpin solution; targeting thrombotic and thrombolytic serine proteases in inflammation.
Chen H; Davids JA; Zheng D; Bryant M; Bot I; van Berckel TJ; Biessen E; Pepine C; Ryman K; Progulski-Fox A; Kesavalu L; Moyer R; McFadden G; Lucas A
Cardiovasc Hematol Disord Drug Targets; 2013 Aug; 13(2):99-110. PubMed ID: 23987998
[TBL] [Abstract][Full Text] [Related]
7. Deriving Immune-Modulating Peptides from Viral Serine Protease Inhibitors (Serpins).
Yaron JR; Zhang L; Burgin M; Schutz LN; Awo EA; Keinan S; McFadden G; Ambadapadi S; Guo Q; Chen H; Lucas AR
Methods Mol Biol; 2021; 2225():107-123. PubMed ID: 33108660
[TBL] [Abstract][Full Text] [Related]
8. Viral serpin therapeutics from concept to clinic.
Chen H; Zheng D; Davids J; Bartee MY; Dai E; Liu L; Petrov L; Macaulay C; Thoburn R; Sobel E; Moyer R; McFadden G; Lucas A
Methods Enzymol; 2011; 499():301-29. PubMed ID: 21683260
[TBL] [Abstract][Full Text] [Related]
9. Secreted immunomodulatory viral proteins as novel biotherapeutics.
Lucas A; McFadden G
J Immunol; 2004 Oct; 173(8):4765-74. PubMed ID: 15470015
[TBL] [Abstract][Full Text] [Related]
10. Viral serpin, Serp-1, inhibits endogenous angiogenesis in the chicken chorioallantoic membrane model.
Richardson M; Liu L; Dunphy L; Wong D; Sun Y; Viswanathan K; Singh G; Lucas A
Cardiovasc Pathol; 2007; 16(4):191-202. PubMed ID: 17637427
[TBL] [Abstract][Full Text] [Related]
11. Suppression of collagen-induced arthritis with a serine proteinase inhibitor (serpin) derived from myxoma virus.
Brahn E; Lee S; Lucas A; McFadden G; Macaulay C
Clin Immunol; 2014 Aug; 153(2):254-63. PubMed ID: 24845791
[TBL] [Abstract][Full Text] [Related]
12. Virus-encoded serine proteinase inhibitor SERP-1 inhibits atherosclerotic plaque development after balloon angioplasty.
Lucas A; Liu L; Macen J; Nash P; Dai E; Stewart M; Graham K; Etches W; Boshkov L; Nation PN; Humen D; Hobman ML; McFadden G
Circulation; 1996 Dec; 94(11):2890-900. PubMed ID: 8941118
[TBL] [Abstract][Full Text] [Related]
13. Myxoma viral serpin, Serp-1, a unique interceptor of coagulation and innate immune pathways.
Viswanathan K; Liu L; Vaziri S; Dai E; Richardson J; Togonu-Bickersteth B; Vatsya P; Christov A; Lucas AR
Thromb Haemost; 2006 Mar; 95(3):499-510. PubMed ID: 16525579
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of transplant vasculopathy in a rat aortic allograft model after infusion of anti-inflammatory viral serpin.
Miller LW; Dai E; Nash P; Liu L; Icton C; Klironomos D; Fan L; Nation PN; Zhong R; McFadden G; Lucas A
Circulation; 2000 Apr; 101(13):1598-605. PubMed ID: 10747355
[TBL] [Abstract][Full Text] [Related]
15. Viral anti-inflammatory serpin reduces immuno-coagulopathic pathology in SARS-CoV-2 mouse models of infection.
Zhang L; Li YH; Kibler K; Kraberger S; Varsani A; Turk J; Elmadbouly N; Aliskevich E; Spaccarelli L; Estifanos B; Enow J; Zanetti IR; Saldevar N; Lim E; Schlievert J; Browder K; Wilson A; Juan FA; Pinteric A; Garg A; Monder H; Saju R; Gisriel S; Jacobs B; Karr TL; Florsheim EB; Kumar V; Wallen J; Rahman M; McFadden G; Hogue BG; Lucas AR
EMBO Mol Med; 2023 Sep; 15(9):e17376. PubMed ID: 37534622
[TBL] [Abstract][Full Text] [Related]
16. The role of protease inhibition with emphasis on the effects of inflammation and vascular immune phenomena.
Bilfinger TV; Stefano GB
Curr Pharm Des; 2002; 8(7):505-9. PubMed ID: 11945155
[TBL] [Abstract][Full Text] [Related]
17. Serpins: Development for Therapeutic Applications.
Lucas A; Yaron JR; Zhang L; Macaulay C; McFadden G
Methods Mol Biol; 2018; 1826():255-265. PubMed ID: 30194606
[TBL] [Abstract][Full Text] [Related]
18. Anti-apoptotic serpins as therapeutics in cardiovascular diseases.
Kuiper J; Quax PH; Bot I
Cardiovasc Hematol Disord Drug Targets; 2013 Aug; 13(2):111-22. PubMed ID: 23987999
[TBL] [Abstract][Full Text] [Related]
19. Myxoma virus derived immune modulating proteins, M-T7 and Serp-1, reduce early inflammation after spinal cord injury in the rat model.
Kwiecien JM; Dabrowski W; Marzec-Kotarska B; Kwiecien-Delaney CJ; Yaron JR; Zhang L; Schutz L; Lucas AR
Folia Neuropathol; 2019; 57(1):41-50. PubMed ID: 31038187
[TBL] [Abstract][Full Text] [Related]
20. The effects of interleukin-1 on articular cartilage destruction as observed in arthritic diseases, and its therapeutic control.
Verschure PJ; Van Noorden CJ
Clin Exp Rheumatol; 1990; 8(3):303-13. PubMed ID: 2199112
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
